Sun Pharma secures CDSCO panel okay for Amantadine ER Tablets to treat Parkinson Medical Dialogues Team30 July 2021 12:35 PM ISTNew Delhi: Pharmaceutical major, Sun Pharma, has got a go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
DCGI classifies 36 cardiovascular medical devices, Details Medical Dialogues Team29 July 2021 9:30 AM ISTNew Delhi: Based on the intended use, risk associated with the device, and other parameters specified in the First Schedule of the Medical Devices...
Withdraw marketing of Durvalumab for metastatic urothelial carcinoma: CDSCO panel tells AstraZeneca Medical Dialogues Team27 July 2021 5:43 PM ISTNew Delhi: In a major setback to AstraZeneca Pharma India Limited., the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Already approved drugs with changes in active substance may be considered as new drug: DCGI Medical Dialogues Team26 July 2021 10:00 AM ISTNew Delhi: The apex drug regulatory body, the Central Drugs Standard Control Organization (CDSCO), has clarified that any changes in...
Include more Govt sites in Dapagliflozin, Teneligliptin FDC phase 3 trial: CDSCO panel tells Macleods Pharma Medical Dialogues Team25 July 2021 11:15 AM ISTNew Delhi: Macleods Pharmaceutical has recently received permission from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Sun Pharma cancer drug Pemetrexed Solution for Infusion gets CDSCO panel okay Medical Dialogues Team23 July 2021 6:23 PM ISTNew Delhi: Pharmaceutical major, Sun Pharma, has got a go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
DCGI classifies 112 medical devices related to anesthesiology Medical Dialogues Team22 July 2021 3:11 PM ISTNew Delhi: In order to regulate the safety, quality and performance of medical devices, Drugs Controller General (India), Directorate General of...
Sun Pharma gets CDSCO panel nod for Tetracosactide injection Medical Dialogues Team21 July 2021 4:06 PM ISTNew Delhi: Sun Pharmaceuticals has got a go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO)...
Cadila Healthcare gets CDSCO panel okay for Fluticasone Furoate, Oxymetazoline HCL nasal spray Medical Dialogues Team19 July 2021 1:00 PM ISTNew Delhi: In a major rejoice for pharma major Cadila Healthcare, the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Glenmark gets CDSCO panel marketing nod to Remogliflozin, Teneligliptin FDC Medical Dialogues Team18 July 2021 11:30 AM ISTNew Delhi: In a major rejoice to Mumbai-based Glenmark Pharmaceuticals Limited, the Subject Expert Committee (SEC) of the Central Drugs Standard...
Sun Pharma secures CDSCO panel nod for Phase 4 trial of Dextromethorphan Hydrobromide, Chlorpheniramine Maleate FDC Medical Dialogues Team14 July 2021 4:19 PM ISTNew Delhi: Pharmaceutical major Sun Pharma has recently secured permission from the Subject Expert Committee (SEC) of the Central Drugs Standard...
Serum Institute gets CDSCO panel nod to conduct clinical trial of Reduced Inactivated Salk Polio Vaccine Medical Dialogues Team13 July 2021 10:15 AM ISTNew Delhi: Vaccine maker Serum Institute of India (SII) has recently got approval from the Subject Expert Committee (SEC) of the Central Drugs...
